Mistry, H. B., Orrell, D., & Eftimie, R. (2017). Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma. Cancer Chemother Pharmacol.
Style de citation ChicagoMistry, Hitesh B., David Orrell, et Raluca Eftimie. "Model Based Analysis of the Heterogeneity in the Tumour Size Dynamics Differentiates Vemurafenib, Dabrafenib and Trametinib in Metastatic Melanoma." Cancer Chemother Pharmacol 2017.
Style de citation MLAMistry, Hitesh B., David Orrell, et Raluca Eftimie. "Model Based Analysis of the Heterogeneity in the Tumour Size Dynamics Differentiates Vemurafenib, Dabrafenib and Trametinib in Metastatic Melanoma." Cancer Chemother Pharmacol 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.